ETP-45835

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameETP-45835
Drug Alias NameETP-45835
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMAP kinase-interacting serine/threonine-protein kinase MNK1 inhibitors
TargetsMAP kinase-interacting serine/threonine-protein kinase MNK1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSpanish National Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSpanish National Cancer Center
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A